Snail1 correlates with patient outcomes in E-cadherin-preserved gastroesophageal junction adenocarcinoma

Clinical and Translational Oncology

Volumn 16, Issue 9, 2014, Pages 783-791

  Dong, H ^a   Xie, L ^a   Tang, C ^b   Chen, S ^a   Liu, Q ^a   Zhang, Q ^a   Zheng, W ^a   Zheng, Z ^a   Zhang, H ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

E cadherin; Epithelial mesenchymal transition; Gastroesophageal junction adenocarcinoma; Snail1

Indexed keywords

TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR SNAIL1; UNCLASSIFIED DRUG; UVOMORULIN; CADHERIN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR; TUMOR MARKER;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISTANT METASTASIS; EPITHELIAL MESENCHYMAL TRANSITION; ESOPHAGEAL ADENOCARCINOMA; FEMALE; GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LOWER ESOPHAGUS SPHINCTER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; ADENOCARCINOMA; AGED; BIOSYNTHESIS; ESOPHAGUS TUMOR; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CADHERINS; EPITHELIAL-MESENCHYMAL TRANSITION; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84906937795     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-013-1149-3     Document Type: Article

References (29)

1. Moehler M, Lyros O, Gockel I, Galle PR, Lang H. Multidisciplinary management of gastric and gastroesophageal cancers. WJG. 2008;14(24):3773-80.
2. Menges M, Hoehler T. Current strategies in systemic treatment of gastric cancer and cancer of the gastroesophageal junction. J Cancer Res Clin Oncol. 2009;135(1):29-38. doi:10.1007/s00432-008-0425-z.
3. Bain GH, Petty RD. Predicting response to treatment in gastroesophageal junction adenocarcinomas: combining clinical, imaging, and molecular biomarkers. Oncologist. 2010;15(3):270-84. doi:10.1634/theoncologist.2009-0293.
4. Nakamura M, Iwahashi M, Nakamori M, Naka T, Ojima T, Iida T, et al. Lower mediastinal lymph node metastasis is an independent survival factor of Siewert type II and III adenocarcinomas in the gastroesophageal junction. Am Surg. 2012;78(5):567-73.
5. Maeda H, Okabayashi T, Nishimori I, Sugimoto T, Namikawa T, Dabanaka K, et al. Clinicopathologic features of adenocarcinoma at the gastric cardia: is it different from distal cancer of the stomach? J Am Coll Surg. 2008;206(2):306-10. doi:10.1016/j.jamcollsurg.2007.06.306.
6. Pedrazzani C, de Manzoni G, Marrelli D, Giacopuzzi S, Corso G, Minicozzi AM, et al. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma. J Thorac Cardiovasc Surg. 2007;134(2):378-85. doi:10.1016/j.jtcvs.2007.03.034. (Pubitemid 47088597)
7. Lagarde SM, ten Kate FJ, de Boer DJ, Busch OR, Obertop H, van Lanschot JJ. Extracapsular lymph node involvement in node-positive patients with adenocarcinoma of the distal esophagus or gastroesophageal junction. Am J Surg Pathol. 2006;30(2):171-6. (Pubitemid 43740185)
8. Gu Y, Swisher SG, Ajani JA, Correa AM, Hofstetter WL, Liao Z, et al. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer. 2006;106(5):1017-25. doi:10.1002/cncr.21693.
9. Matsumoto M, Natsugoe S, Nakashima S, Sakamoto F, Okumura H, Sakita H, et al. Clinical significance of lymph node micrometastasis of pN0 esophageal squamous cell carcinoma. Cancer Lett. 2000;153(1-2):189-97. (Pubitemid 30209862)
10. Yang Z, Zhang H, Kumar R. Regulation of E-cadherin. In: Breast Cancer Online. Cambridge University Press 2005. http://journals.cambridge.org/article- S1470903105003159.
11. Blanco MJ, Moreno-Bueno G, Sarrio D, Locascio A, Cano A, Palacios J, et al. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene. 2002;21(20):3241-6. doi:10.1038/sj.onc. 1205416. (Pubitemid 34548095)
12. Sobin LH, Compton CC. TNM seventh edition: what's new, what's changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer. Cancer. 2010;116(22):5336-9. doi:10.1002/cncr.25537.
13. Zhang H, Stephens LC, Kumar R. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer. Clin Cancer Res. 2006;12(5):1479-86. doi:10.1158/1078-0432. CCR-05-1519.
14. Natsugoe S, Uchikado Y, Okumura H, Matsumoto M, Setoyama T, Tamotsu K, et al. Snail plays a key role in E-cadherin-preserved esophageal squamous cell carcinoma. Oncol Rep. 2007;17(3):517-23.
15. Uchikado Y, Okumura H, Ishigami S, Setoyama T, Matsumoto M, Owaki T, et al. Increased Slug and decreased E-cadherin expression is related to poor prognosis in patients with gastric cancer. Gastric cancer: Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc. 2011;14(1):41-9. doi:10.1007/s10120-011- 0004-x.
16. Rosivatz E, Becker I, Specht K, Fricke E, Luber B, Busch R, et al. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am J Pathol. 2002;161(5):1881-91. doi:10.1016/S0002-9440(10)64464-1. (Pubitemid 35265545)
17. He H, Chen W, Wang X, Wang C, Liu F, Shen Z, et al. Snail is an independent prognostic predictor for progression and patient survival of gastric cancer. Cancer Sci. 2012;103(7):1296-303. doi:10.1111/j.1349-7006.2012.02295.x.
18. Stanculescu D, Margaritescu C, Stepan A, Mitrut AO. E-cadherin in gastric carcinomas related to histological prognostic parameters. Rom J Morphol Embryology = Revue Roumaine de Morphologie et Embryologie. 2011;52(3 Suppl):1107-12.
19. Chan AO. E-cadherin in gastric cancer. World J Gastroenterol: WJG. 2006;12(2):199-203. (Pubitemid 43336917)
20. Wang ZS, Shen Y, Li X, Zhou CZ, Wen YG, Jin YB, et al. Significance and prognostic value of Gli-1 and Snail/E-cadherin expression in progressive gastric cancer. Tumour Biol: J Int Soc Oncodevelopmental Biol Med. 2013;. doi:10.1007/s13277-013-1185-1.
21. Rosivatz E, Becker KF, Kremmer E, Schott C, Blechschmidt K, Hofler H, et al. Expression and nuclear localization of Snail, an E-cadherin repressor, in adenocarcinomas of the upper gastrointestinal tract. Virchows Arch: Int J Pathol. 2006;448(3):277-87. doi:10.1007/s00428-005-0118-9. (Pubitemid 43357643)
22. Li SL, Gao DL, Zhao ZH, Liu ZW, Zhao QM, Yu JX, et al. Correlation of matrix metalloproteinase suppressor genes RECK, VEGF, and CD105 with angiogenesis and biological behavior in esophageal squamous cell carcinoma. WJG. 2007;13(45):6076-81. (Pubitemid 350238279)
23. Sung CO, Park CK, Kim SH. Classification of epithelial-mesenchymal transition phenotypes in esophageal squamous cell carcinoma is strongly associated with patient prognosis. Mod Pathol: Off J U. S. Can Acad Pathol, Inc. 2011;24(8):1060-8. doi:10.1038/modpathol.2011.59.
24. Barbera MJ, Puig I, Dominguez D, Julien-Grille S, Guaita-Esteruelas S, Peiro S, et al. Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells. Oncogene. 2004;23(44):7345-54. doi:10.1038/sj.onc.1207990. (Pubitemid 39382137)
25. Guo HM, Zhang XQ, Xu CH, Zou XP. Inhibition of invasion and metastasis of gastric cancer cells through snail targeting artificial microRNA interference. Asian Pac J Cancer Prev: APJCP. 2011;12(12):3433-8.
26. Castro Alves C, Rosivatz E, Schott C, Hollweck R, Becker I, Sarbia M, et al. Slug is overexpressed in gastric carcinomas and may act synergistically with SIP1 and Snail in the down-regulation of E-cadherin. J Pathol. 2007;211(5):507-15. doi:10.1002/path.2138.
27. Sawada K, Mitra AK, Radjabi AR, Bhaskar V, Kistner EO, Tretiakova M, et al. Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target. Cancer Res. 2008;68(7):2329-39. doi:10.1158/0008-5472.CAN-07-5167. (Pubitemid 351521807)
28. Olmeda D, Jorda M, Peinado H, Fabra A, Cano A. Snail silencing effectively suppresses tumour growth and invasiveness. Oncogene. 2007;26(13):1862-74. doi:10.1038/sj.onc.1209997. (Pubitemid 46474642)
29. Roy HK, Iversen P, Hart J, Liu Y, Koetsier JL, Kim Y, et al. Down-regulation of SNAIL suppresses MIN mouse tumorigenesis: modulation of apoptosis, proliferation, and fractal dimension. Mol Cancer Ther. 2004;3(9):1159-65. (Pubitemid 39295013)